Key Insights
The South Korea neurology devices market, valued at approximately $XX million in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 6.80% from 2025 to 2033. This expansion is driven by several key factors. An aging population, coupled with rising prevalence of neurological disorders like stroke, Parkinson's disease, and Alzheimer's disease, fuels increased demand for advanced diagnostic and therapeutic devices. Furthermore, the South Korean government's focus on improving healthcare infrastructure and technological advancements in minimally invasive neurosurgical procedures contribute significantly to market growth. Growing awareness among patients about the benefits of neurology devices and increased healthcare expenditure are also positive contributors. The market is segmented into various categories including neurostimulation devices (deep brain stimulation, spinal cord stimulation), cerebrospinal fluid management devices, interventional neurology devices (thrombectomy systems, aneurysm coils), and support devices. While the precise market share of each segment is unavailable, it's reasonable to infer that neurostimulation and interventional neurology devices represent substantial portions given global trends and the advanced medical infrastructure in South Korea. Competition within the market is fierce, with key players including international giants such as Medtronic, Johnson & Johnson, and Stryker, alongside other prominent regional companies. These companies are actively engaged in research and development, striving to introduce innovative products with improved functionalities and efficacy.
Despite the positive outlook, the market faces certain challenges. High costs associated with advanced neurology devices and limited reimbursement policies may hinder market penetration, particularly in the private sector. Furthermore, stringent regulatory approvals for new device launches and potential supply chain disruptions can pose obstacles to market growth. However, technological advancements, increased government funding for research, and the growing adoption of telemedicine are expected to mitigate these challenges and bolster the market's long-term trajectory. The continuous development of innovative neurosurgical techniques and minimally invasive procedures will further drive market growth in the coming years. Successful navigation of these challenges will be key to realizing the full potential of the South Korea neurology devices market.

South Korea Neurology Devices Market: A Comprehensive Report (2019-2033)
This in-depth report provides a comprehensive analysis of the South Korea neurology devices market, covering market size, segmentation, growth drivers, challenges, and key players. The study period spans from 2019 to 2033, with 2025 serving as the base and estimated year. The report offers actionable insights for industry stakeholders, including manufacturers, distributors, and investors.
South Korea Neurology Devices Market Concentration & Innovation
The South Korea neurology devices market exhibits a moderately concentrated landscape, with a few multinational corporations holding significant market share. Key players like Smith & Nephew, Integra LifeSciences Corporation, Abbott Laboratories, Johnson & Johnson, Medtronic PLC, Elekta AB, Stryker Corporation, and B Braun SE dominate the market. However, the market also features several smaller, specialized companies focusing on niche segments. Market share data indicates that the top five players collectively hold approximately xx% of the market, suggesting a competitive but not overly fragmented environment. The market concentration is influenced by factors such as stringent regulatory approvals, high R&D investments, and the need for specialized distribution networks.
Innovation in the South Korean neurology devices market is driven by factors such as an aging population, increasing prevalence of neurological disorders, and advancements in medical technology. The regulatory framework, while stringent, encourages innovation through various incentives and expedited approval processes for innovative devices. Substitutes for certain neurology devices exist, particularly in minimally invasive procedures, creating competitive pressure. End-user trends show a growing preference for minimally invasive and less-invasive procedures, driving the demand for advanced devices. M&A activities in the sector are relatively moderate, with deal values averaging approximately xx Million annually over the past five years, reflecting a focus on organic growth and strategic partnerships rather than large-scale acquisitions.
South Korea Neurology Devices Market Industry Trends & Insights
The South Korea neurology devices market is experiencing robust growth, with a projected CAGR of xx% during the forecast period (2025-2033). This growth is primarily fueled by several key factors. The rising prevalence of neurological disorders, including stroke, Alzheimer's disease, and Parkinson's disease, coupled with an aging population, is significantly increasing the demand for neurology devices. Technological advancements, such as minimally invasive surgical techniques and advanced neuroimaging technologies, are enhancing the diagnostic and therapeutic capabilities of neurology devices. Furthermore, increasing government healthcare spending and rising disposable incomes are making advanced medical technologies more accessible to the South Korean population. Consumer preferences are shifting towards minimally invasive procedures and technologically advanced devices that offer improved outcomes and reduced recovery time. The competitive dynamics are characterized by both intense competition among established players and the emergence of innovative start-ups offering new and improved devices. Market penetration of advanced neurology devices is expected to increase from xx% in 2025 to xx% by 2033.

Dominant Markets & Segments in South Korea Neurology Devices Market
By Type of Device: Interventional neurology devices represent the largest segment, driven by the increasing prevalence of stroke and other cerebrovascular diseases requiring immediate intervention. The cerebrospinal fluid management devices segment is also experiencing significant growth due to the increasing incidence of hydrocephalus and other neurological conditions requiring CSF management.
Other Neurosurgery Devices: Neurostimulation devices are growing rapidly, owing to the rising demand for minimally invasive treatment options for chronic pain and neurological disorders. The "Other Types of Devices" segment includes a range of products with moderate growth potential.
Support Devices: Neurosurgery support devices, including surgical instruments and implants, exhibit steady growth, reflecting the increasing number of neurosurgical procedures performed.
The dominance of the interventional neurology devices segment is attributed to several factors, including the high prevalence of stroke and other acute neurological conditions, the increasing adoption of minimally invasive procedures, and technological advancements in neurointerventional techniques. The growth of this segment is further fueled by government initiatives promoting stroke prevention and improved stroke care. Economic policies supporting healthcare infrastructure development and investments in medical technology also contribute to this dominance.
South Korea Neurology Devices Market Product Developments
Recent product innovations focus on minimally invasive procedures, improved device safety and efficacy, and enhanced patient outcomes. The development of advanced neuroimaging technologies allows for more precise diagnosis and targeted treatment. Companies are focusing on developing devices that are easier to use and more efficient to reduce procedure times and improve patient recovery. This is also driving the adoption of smart technologies and data analytics to enhance the effectiveness of treatments. The market fit for these innovations is excellent, driven by the unmet needs within the neurology sector and the willingness of healthcare providers to adopt newer and more effective devices.
Report Scope & Segmentation Analysis
This report segments the South Korea neurology devices market based on device type (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurostimulation Devices, Other Neurostimulation Devices, Support Devices: Neurosurgery Devices) and provides a detailed analysis of each segment’s market size, growth projections, and competitive landscape. Growth projections vary by segment, reflecting the unique dynamics of each. For instance, the Interventional Neurology Devices segment is projected to witness the highest CAGR due to the rising prevalence of stroke. Competitive dynamics are influenced by factors such as technological advancements, regulatory approvals, and pricing strategies.
Key Drivers of South Korea Neurology Devices Market Growth
The South Korea neurology devices market is propelled by several key factors. The aging population leading to an increased prevalence of neurological diseases significantly boosts demand. Technological advancements resulting in minimally invasive, more efficient, and safer devices contribute to market growth. Government support and funding for healthcare infrastructure and technological improvements further stimulate market expansion. The rising disposable income of the population increases accessibility to advanced medical technologies.
Challenges in the South Korea Neurology Devices Market Sector
The South Korea neurology devices market faces several challenges. The stringent regulatory approval process for medical devices can delay product launches and increase development costs. Supply chain disruptions, especially exacerbated by global events, can impact device availability and pricing. Intense competition among established players and emerging companies puts pressure on pricing and profitability. These factors may collectively impact the market's overall growth trajectory.
Emerging Opportunities in South Korea Neurology Devices Market
Emerging opportunities in the South Korea neurology devices market include the growing adoption of telemedicine and remote patient monitoring technologies. The increasing focus on personalized medicine and the development of targeted therapies are promising avenues for innovation. The increasing demand for minimally invasive procedures and less invasive solutions continues to drive opportunities for new devices and treatments.
Leading Players in the South Korea Neurology Devices Market Market
- Smith & Nephew
- Integra LifeSciences Corporation
- Abbott Laboratories
- Johnson & Johnson
- Medtronic PLC
- Elekta AB
- Stryker Corporation
- B Braun SE
Key Developments in South Korea Neurology Devices Market Industry
- July 2021: Neurolief secured an exclusive licensing agreement with NeuroFront for Relivion's commercialization in Greater China and South Korea. This significantly expanded the market reach for this non-invasive migraine and depression treatment device.
- March 2022: GE Healthcare and Seoul National University Bundang Hospital (SNUBH) formed a partnership to leverage GE Healthcare’s Edison Digital Health Platform, potentially improving healthcare data management and analysis within South Korea.
Strategic Outlook for South Korea Neurology Devices Market Market
The South Korea neurology devices market holds significant future potential driven by continued demographic shifts, technological innovation, and supportive government policies. The focus on minimally invasive procedures, improved diagnostics, and personalized medicine presents lucrative opportunities for market players. Companies that invest in research and development, focus on innovative product development, and establish strong distribution networks are well-positioned to capitalize on the market's growth trajectory.
South Korea Neurology Devices Market Segmentation
-
1. Type of Device
- 1.1. Cerebrospinal Fluid Management Devices
-
1.2. Interventional Neurology Devices
- 1.2.1. Interventional/Surgical Simulators
- 1.2.2. Neurothrombectomy Devices
- 1.2.3. Carotid Artery Stents
- 1.2.4. Embolic Coils
- 1.2.5. Support Devices
-
1.3. Neurosurgery Devices
- 1.3.1. Neuroendoscopes
- 1.3.2. Stereotactic Systems
- 1.3.3. Aneurysm Clips
- 1.3.4. Other Neurosurgery Devices
-
1.4. Neurostimulation Devices
- 1.4.1. Spinal Cord Stimulation Devices
- 1.4.2. Deep Brain Stimulation Devices
- 1.4.3. Sacral Nerve Stimulation Devices
- 1.4.4. Other Neurostimulation Devices
- 1.5. Other Types of Devices
South Korea Neurology Devices Market Segmentation By Geography
- 1. South Korea

South Korea Neurology Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.80% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increase in Incidence of Neurological Disorders; Increasing R&D and Huge Investments by Private Players in Neurology Devices
- 3.3. Market Restrains
- 3.3.1. High Cost of Equipment
- 3.4. Market Trends
- 3.4.1. Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. South Korea Neurology Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 5.1.1. Cerebrospinal Fluid Management Devices
- 5.1.2. Interventional Neurology Devices
- 5.1.2.1. Interventional/Surgical Simulators
- 5.1.2.2. Neurothrombectomy Devices
- 5.1.2.3. Carotid Artery Stents
- 5.1.2.4. Embolic Coils
- 5.1.2.5. Support Devices
- 5.1.3. Neurosurgery Devices
- 5.1.3.1. Neuroendoscopes
- 5.1.3.2. Stereotactic Systems
- 5.1.3.3. Aneurysm Clips
- 5.1.3.4. Other Neurosurgery Devices
- 5.1.4. Neurostimulation Devices
- 5.1.4.1. Spinal Cord Stimulation Devices
- 5.1.4.2. Deep Brain Stimulation Devices
- 5.1.4.3. Sacral Nerve Stimulation Devices
- 5.1.4.4. Other Neurostimulation Devices
- 5.1.5. Other Types of Devices
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. South Korea
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Smith & Nephew
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Integra LifeSciences Corporation*List Not Exhaustive
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Abbott Laboratories
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Johnson and Johnson
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Medtronic PLC
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Elekta AB
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Stryker Corporation
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 B Braun SE
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.1 Smith & Nephew
List of Figures
- Figure 1: South Korea Neurology Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: South Korea Neurology Devices Market Share (%) by Company 2024
List of Tables
- Table 1: South Korea Neurology Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: South Korea Neurology Devices Market Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 3: South Korea Neurology Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 4: South Korea Neurology Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 5: South Korea Neurology Devices Market Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 6: South Korea Neurology Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the South Korea Neurology Devices Market?
The projected CAGR is approximately 6.80%.
2. Which companies are prominent players in the South Korea Neurology Devices Market?
Key companies in the market include Smith & Nephew, Integra LifeSciences Corporation*List Not Exhaustive, Abbott Laboratories, Johnson and Johnson, Medtronic PLC, Elekta AB, Stryker Corporation, B Braun SE.
3. What are the main segments of the South Korea Neurology Devices Market?
The market segments include Type of Device.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increase in Incidence of Neurological Disorders; Increasing R&D and Huge Investments by Private Players in Neurology Devices.
6. What are the notable trends driving market growth?
Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Equipment.
8. Can you provide examples of recent developments in the market?
In March 2022, GE Healthcare and Seoul National University Bundang Hospital (SNUBH) entered a memorandum of understanding to explore opportunities for SNUBH to leverage the Edison Digital Health Platform and related services from GE Healthcare.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "South Korea Neurology Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the South Korea Neurology Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the South Korea Neurology Devices Market?
To stay informed about further developments, trends, and reports in the South Korea Neurology Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence